Report Highlights
INTRODUCTION
Despite an extended Enron-like ice bath from Imclone and others that compounded pipeline problems in biotech/pharma —freezing investments for most of 2002—the chill was somewhat held off for the year in the hospital and medical device markets by sunny supply and demand conditions. Reimbursement and regulatory bugs aside, the more temperate regions of the medical industry were warmed by the expanding health needs of aging Americans — needs that translated to nearly 15% of the national economy for the year —up from 13% last year, according to the government. Based on the demographic trend, and a year-ending rebound for biotech, analysts say the medical arena should do as well or better in 2003.
BIOTECH
In the tight economy, scores of biotech companies made cuts in research projects and staffing during the second half of the year. Even so, biotech raised more than $10 billion, with more venture capital flowing into the industry in 2002 than ever, a record $2.6 billion. As investments returned in the fourth quarter, hopes were raised that the biotech bottom had been struck. Market capitalization for the industry rose from $219 billion at the end of October to $225 billion as of December 9 —an increase of 3% for the month and a half.
HOSPITALS
Overall, the hospital sector continued to benefit from large admissions and high demand in 2002. According to Merrill Lynch, the increasing ailments of middle aged and older Americans fueled 20% to 60% returns for hospital management companies. Such returns should continue in the coming year and beyond, with the 55 year-old to 64 year-old age group increasing by 54% between the years 1996 and 2006. When patients enter that group, their average healthcare spending increases dramatically — for males in particular the spending doubles from the previous group, according to PricewaterhouseCoopers Partner David Chin. However, superannuated Boomers are proving tough customers, pressuring hospitals to provide more advanced services, including the latest in pharmaceutical and medical technologies.
MEDICAL DEVICES
The growing patient population and their insistence on the latest and most advanced technology has not hurt the device industry. Previously overlooked by investors, the sector found itself squarely under the speculative spotlight in 2002. More money than ever was committed to device companies for the year, based on a surprising solidity in bad times. The sector lost a mere 2% in valuations, a pittance compared to losses in other industries such as high tech and biotech, according to a VentureOne study.
This anthology keeps you informed of key developments affecting companies worldwide that rely on high-technology materials to develop economical new treatments and devises.
Related Reports
Recent Reports
Medical Magnetic Resonance Imaging (MRI): Technologies and Global Markets
The global market for medical magnetic resonance imaging (MRI) is expected to grow from $7.2 billion in 2023 and projected to reach $9.8 billion by the end of 2028, at a compound annual growth rate (CAGR) of 6.4% during the forecast period of 2023 to 2028.
Global Markets for Emerging Insulin Drug and Delivery Technologies: Focus on Syringes and Vials
The global market for emerging insulin drug delivery devices is expected to grow from $55.8 billion in 2023 and projected to reach $88.9 billion by the end of 2028, at a compound annual growth rate (CAGR) of 9.8% from 2023 through 2028.
Global Cleanroom Technology Market
The global market for cleanroom products is expected to grow from $7.5 billion in 2023 to $10.9 billion by the end of 2028, at a compound annual growth rate (CAGR) of 7.6% from 2023 through 2028.
Ophthalmic Devices, Diagnostics and Surgical Equipment: Global Markets
The global market for ophthalmic devices, diagnostics and surgical equipment is expected to grow from $32.5 billion in 2023 and forecast to reach $44.0 billion by the end of 2028, at a compound annual growth rate (CAGR) of 6.3% from 2023 to 2028.
Microelectromechanical Systems (MEMS) in Global Medical Markets
The global market for microelectromechanical systems (MEMS) devices in medical applications is estimated to increase from $4.8 billion in 2023 to reach $7.2 billion by 2028, at a compound annual growth rate (CAGR) of 8.5% from 2023 through 2028.
Top Trending Reports
Cell and Gene Therapy Tools, and Reagents: Global Markets
The global market for cell and gene therapy tools and reagents is estimated to grow from $8.3 billion in 2022 to $13.7 billion in 2027, with a compound annual growth rate (CAGR) of 10.6% for the period of 2022-2027.
ESG Trends in Chemical Industry
This report focuses on the ESG trends in the chemical industry and evaluates the ESG implementation including current and future potential. The report utilizes various databases, including sustainability reports, annual reports, and other indicators used to develop the current market. The study provides detailed information on the main factors influencing ESG growth in the chemical industry. It enables the reader to understand the industry in general while also providing insight into the inter-relationship between ESG and the sustainable chemical industry. The report describes market growth, developing trends, industry leaders, and applications of ESG implementation in the chemical industry.
Digital Pathology: Technologies and Global Markets
The global digital pathology market is estimated to increase from $5.9 billion in 2022 to reach $10.7 billion by 2027, at a compound annual growth rate (CAGR) of 12.5% from 2022 through 2027.
Smartphone-Based Patient Monitoring: Global Market
The global smartphone-based patient monitoring market should reach $21.5 billion by 2027 from $6.8 billion in 2022 at a compound annual growth rate (CAGR) of 25.9% for the forecast period of 2022 to 2027.
Seawater and Brackish Water Desalination
The global market for seawater and brackish water desalination is estimated to increase from $14.7 billion in 2022 to $21.7 billion by 2027, at a compound annual growth rate (CAGR) of 8.1% from 2022 through 2027.
Become A Member
BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.
Find Out MoreCustom Consulting
BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.
Customize NowScorecard
The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.
Find Out MoreInnovation Spotlight
Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.
Find Out More